Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 2491 AL 2505

Potentiation of microglial endocannabinoid signaling alleviates neuroinflammation in Alzheimer's disease

Rapaka D, Bitra VR, Challa SR, Adiukwu PC.

Neuropeptides. 2021 Dec;90:102196. doi: 10.1016/j.npep.2021.102196. Epub 2021 Sep 2.

Engrafted stem cell therapy for Alzheimer's disease: A promising treatment strategy with clinical outcome

Salwa, Kumar L.

J Control Release. 2021 Oct 10;338:837-857. doi: 10.1016/j.jconrel.2021.09.007. Epub 2021 Sep 9.

Impact of an educational programme on Alzheimer's disease patients' quality of life: results of the randomized controlled trial THERAD

Villars H, Cantet C, de Peretti E, Perrin A, Soto-Martin M, Gardette V.

Alzheimers Res Ther. 2021 Sep 12;13(1):152. doi: 10.1186/s13195-021-00896-3.

Noncanonical Metabotropic Glutamate Receptor 5 Signaling in Alzheimer's Disease

Abd-Elrahman KS, Ferguson SSG.

Annu Rev Pharmacol Toxicol. 2022 Jan 6;62:235-254. doi: 10.1146/annurev-pharmtox-021821-091747. Epub 2021 Sep 13.

Preclinical and clinical evidence of NAD(+) precursors in health, disease, and ageing

Reiten OK, Wilvang MA, Mitchell SJ, Hu Z, Fang EF.

Mech Ageing Dev. 2021 Oct;199:111567. doi: 10.1016/j.mad.2021.111567. Epub 2021 Sep 10.

Effects of Body Weight on the Safety of High-Dose Donepezil in Alzheimer's Disease: Post hoc Analysis of a Multicenter, Randomized, Open-Label, Parallel Design, Three-Arm Clinical Trial

Hong YJ, Han HJ, Youn YC, Park KW, Yang DW, Kim S, Kim HJ, Kim HJ, Lee Y, Kwon M, Lee JH; ODESA study (Optimal Dose Escalation Strategy to Successful Achievement of High Dose Donepezil 23 mg).

Dement Geriatr Cogn Disord. 2021;50(3):289-295. doi: 10.1159/000518470. Epub 2021 Sep 10.

Research Progress on Mechanism of Neuroprotective Roles of Apelin-13 in Prevention and Treatment of Alzheimer's Disease

Wan T, Fu M, Jiang Y, Jiang W, Li P, Zhou S.

Neurochem Res. 2022 Feb;47(2):205-217. doi: 10.1007/s11064-021-03448-1. Epub 2021 Sep 13.

Intracerebroventricular injection of human umbilical cord blood mesenchymal stem cells in patients with Alzheimer's disease dementia: a phase I clinical trial

Kim HJ, Cho KR, Jang H, Lee NK, Jung YH, Kim JP, Lee JI, Chang JW, Park S, Kim ST, Moon SW, Seo SW, Choi SJ, Na DL.

Alzheimers Res Ther. 2021 Sep 14;13(1):154. doi: 10.1186/s13195-021-00897-2.

Neuroprotective potential of berberine in modulating Alzheimer's disease via multiple signaling pathways

Akbar M, Shabbir A, Rehman K, Akash MSH, Shah MA.

J Food Biochem. 2021 Oct;45(10):e13936. doi: 10.1111/jfbc.13936. Epub 2021 Sep 14.

The Beneficial Role of Natural Endocrine Disruptors: Phytoestrogens in Alzheimer's Disease

Domańska A, Orzechowski A, Litwiniuk A, Kalisz M, Bik W, Baranowska-Bik A.

Oxid Med Cell Longev. 2021 Sep 3;2021:3961445. doi: 10.1155/2021/3961445. eCollection 2021.

Safe and Effective Disease-Modifying Therapies for Small Blood Vessel Disease in the Brain

Arboleda-Velasquez JF.

Am J Pathol. 2021 Nov;191(11):1852-1855. doi: 10.1016/j.ajpath.2021.09.003. Epub 2021 Sep 14.

Cannabinoids for the treatment of dementia

Bosnjak Kuharic D, Markovic D, Brkovic T, Jeric Kegalj M, Rubic Z, Vuica Vukasovic A, Jeroncic A, Puljak L.

Cochrane Database Syst Rev. 2021 Sep 17;9(9):CD012820. doi: 10.1002/14651858.CD012820.pub2.

Can we learn lessons from the FDA's approval of aducanumab?

Liu KY, Howard R.

Nat Rev Neurol. 2021 Nov;17(11):715-722. doi: 10.1038/s41582-021-00557-x. Epub 2021 Sep 17.

Cognitive Heterogeneity in Alzheimer Clinical Trials: Harnessing Noise to Achieve Meaningfulness

Buckley RF, Knopman DS.

Neurology. 2021 Jun 1;96(22):1017-1018. doi: 10.1212/WNL.0000000000012027.

Autophagy in Alzheimer's disease pathogenesis: Therapeutic potential and future perspectives

Zhang Z, Yang X, Song YQ, Tu J.

Ageing Res Rev. 2021 Dec;72:101464. doi: 10.1016/j.arr.2021.101464. Epub 2021 Sep 20.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias